Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172755 | SCV000051395 | benign | Primary dilated cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000036845 | SCV000060500 | benign | not specified | 2013-08-07 | criteria provided, single submitter | clinical testing | Asp117Asn in exon 6 of LDB3: This variant is not expected to have clinical signi ficance because it has been identified in 1.3% (51/4090) of African American chr omosomes from a broad population by the NHLBI Exome Sequencing Project (http://e vs.gs.washington.edu/EVS; dbSNP rs121908338). It has been reported in 2 individu als with DCM and 1 individual with LVNC (Vatta 2002, Xi 2012). In vitro studies suggest that it may have functional consequences (Xi 2012), though it should be noted that in vitro studies may not accurately represent biological function and /or may not translate to disease. In summary, the frequency of this variant in the general population suggests that it does not cause disease on its own. It re mains possible that it modifies disease expression. |
Gene |
RCV000224167 | SCV000170110 | benign | not provided | 2018-12-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 14662268, 26636822, 26419279, 28416588, 22929165, 23299917, 22995991, 22619057, 27884173, 27896284, 30293248, 30972196, 25214167) |
Eurofins Ntd Llc |
RCV000036845 | SCV000230992 | benign | not specified | 2015-01-23 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224167 | SCV000281105 | likely benign | not provided | 2016-04-01 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV000234167 | SCV000289629 | benign | Myofibrillar myopathy 4 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000036845 | SCV000306367 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000618022 | SCV000735294 | benign | Cardiovascular phenotype | 2016-01-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000172755 | SCV000995322 | benign | Primary dilated cardiomyopathy | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000004998 | SCV001265379 | uncertain significance | Dilated cardiomyopathy 1C | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
ARUP Laboratories, |
RCV000224167 | SCV001471544 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000036845 | SCV001476527 | benign | not specified | 2020-01-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000224167 | SCV004033061 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | LDB3: BP4, BS1, BS2 |
OMIM | RCV000004998 | SCV000025174 | uncertain significance | Dilated cardiomyopathy 1C | 2003-12-03 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000224167 | SCV001740939 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000036845 | SCV001917870 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000036845 | SCV001930144 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000036845 | SCV001951300 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000224167 | SCV001966188 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224167 | SCV002036194 | likely benign | not provided | no assertion criteria provided | clinical testing |